The Journal of Experimental Medicine
ELISpot, FluoroSpot and ELISA kits from Mabtech
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 238K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thatte, J.
Right arrow Articles by Ward, E. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thatte, J.
Right arrow Articles by Ward, E. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1999/2/509/ $5.00
The Journal of Experimental Medicine, Volume 189, Number 3, February 1, 1999 509-520


Articles

Molecular Requirements for T Cell Recognition by a Major Histocompatibility Complex Class II–restricted T Cell Receptor: The Involvement of the Fourth Hypervariable Loop of the V{alpha} Domain

Jayant Thatte, Ayub Qadri, Caius Radu, and E. Sally Ward

From the Center for Immunology and Department of Microbiology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75235-8576

The role of two central residues (K68, E69) of the fourth hypervariable loop of the V{alpha} domain (HV4{alpha}) in antigen recognition by an MHC class II–restricted T cell receptor (TCR) has been analyzed. The TCR recognizes the NH2-terminal peptide of myelin basic protein (Ac1-11, acetylated at NH2 terminus) associated with the class II MHC molecule I-Au. Lysine 68 (K68) and glutamic acid 69 (E69) of HV4{alpha} have been mutated both individually and simultaneously to alanine (K68A, E69A). The responsiveness of transfectants bearing wild-type and mutated TCRs to Ac1-11–I-Au complexes has been analyzed in the presence and absence of expression of the coreceptor CD4. The data demonstrate that in the absence of CD4 expression, K68 plays a central role in antigen responsiveness. In contrast, the effect of mutating E69 to alanine is less marked. CD4 coexpression can partially compensate for the loss of activity of the K68A mutant transfectants, resulting in responses that, relative to those of the wild-type transfectants, are highly sensitive to anti-CD4 antibody blockade. The observations support models of T cell activation in which both the affinity of the TCR for cognate ligand and the involvement of coreceptors determine the outcome of the T cell–antigen-presenting cell interaction.

Key Words: T cell receptor • V{alpha} domain • fourth hypervariable loop • antigen recognition • CD4 coreceptor


Address correspondence to E. Sally Ward, Center for Immunology and Department of Microbiology, University of Texas Southwestern Medical Center at Dallas, 6000 Harry Hines Blvd., Dallas, TX 75235-8576. Phone: 214-648-1260; Fax: 214-648-1259; E-mail: sally{at}skylab.swmed.edu

A. Qadri's present address is National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110067, India.

1 Abbreviations used in this paper: APC, antigen-presenting cell; CD, circular dichroism; CDR, complementarity determining region; E69, glutamic acid 69; E69A, mutation of E69 to alanine; HV4{alpha}, the fourth hypervariable loop of the V{alpha} domain; ITAM, immune receptor tyrosine-based activation motif; K68, Lysine 68; K68A, mutation of K68 to alanine; MBP, myelin basic protein; PBS, phosphate-buffered saline; pMHC, peptide– major histocompatibility complex; TCR, T cell receptor.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS